SCHEMBL3101065

SCHEMBL3101065

CCC(=O)N(CC1CCN(CCc2ccccc2)CC1)c1cccc(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 11/20 0.63
HTR1A P08908 1/20 0.60
SLC6A4 P31645 1/20 0.60
OPRD1 P41143 2/20 0.58
OPRK1 P41145 2/20 0.58
ACHE P22303 1/20 0.58
SLC22A1 O15245 1/20 0.56
NR1I2 O75469 1/20 0.56
ABCB1 P08183 1/20 0.56
CHRM1 P11229 1/20 0.56
DRD2 P14416 1/20 0.56
ADRA2B P18089 1/20 0.56
ADRA2C P18825 1/20 0.56
CHRM3 P20309 1/20 0.56
MAOA P21397 1/20 0.56
DRD4 P21917 1/20 0.56
MAOB P27338 1/20 0.56
ADRA1A P35348 1/20 0.56
HRH1 P35367 1/20 0.56
ADRA1B P35368 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3091419 0.92 OPRM1 (0.53) OPRM1HTR1ASLC6A4OPRD1OPRK1
SCHEMBL3091628 0.89 OPRM1 (0.75) OPRM1
SCHEMBL3094944 0.88 OPRM1 (0.68) OPRM1OPRD1OPRK1ACHESLC22A1
Hydrochloric Acid SCHEMBL3089658 0.87 OPRM1 (0.67) OPRM1OPRD1OPRK1ACHESLC22A1
SCHEMBL3091587 0.86 OPRM1 (0.63) OPRM1OPRD1OPRK1ACHESLC22A1
SCHEMBL4545439 0.84 OPRM1 (0.81) OPRM1OPRD1OPRK1SLC22A1NR1I2
SCHEMBL3089648 0.82 OPRM1 (0.63) OPRM1OPRD1OPRK1ACHESLC22A1
SCHEMBL3091530 0.81 OPRM1 (0.59) OPRM1OPRD1OPRK1ACHESLC22A1
SCHEMBL3083010 0.81 OPRM1 (0.65) OPRM1OPRD1OPRK1SLC22A1NR1I2
SCHEMBL3083237 0.81 OPRM1 (0.59) OPRM1OPRD1OPRK1ACHESLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234427-A1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-09-16 US claimed
EP-1987001-B1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NEUROSEARCH AS (DK) 2010-05-05 EP claimed
US-20100234427-A1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2010-09-16 US disclosed
EP-1987001-B1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NEUROSEARCH AS (DK) 2010-05-05 EP disclosed
EP-1987001-A1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NeuroSearch A/S (DK) 2008-11-05 EP disclosed
WO-2007093603-A1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS NEUROSEARCH A/S (DK) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234427-A1 1-PHENETHYLPIPERIDINE DERIVATIVES AND THEIR USE AS OPIOID RECEPTOR LIGANDS OPRL1, OPRM1, OPRK1 OPRM1 2/4885HTR1A 33/4885SLC6A4 636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.